clearmindlogo.png
Clearmind Medicine Obtains IND Approval from the FDA to Start the Phase I/IIa Clinical Trial with its Innovative Treatment for Alcoholism
July 16, 2024 09:02 ET | Clearmind Medicine Inc.
Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and...
scilogo.jpg
SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss
July 16, 2024 06:03 ET | SciSparc Ltd
TEL AVIV, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
Asthma Affects 27 Million People in the U.S.
AAFA Co-Hosts Congressional Briefing Highlighting 25th Year of National Asthma Control Program
May 07, 2024 07:00 ET | Asthma and Allergy Foundation of America
Washington, DC, May 07, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is celebrating the 25th year of the CDC’s National Asthma Control Program (NACP) on World Asthma...
LSU Researchers' Noo
LSU Researchers' Nootkatone Studies Could Lead to Prevention of Lyme Disease
April 09, 2024 10:00 ET | LSU College of Engineering
BATON ROUGE, La., April 09, 2024 (GLOBE NEWSWIRE) -- Thanks to a $550,000 National Science Foundation Partnership for Innovation grant—the largest NSF PFI grant ever awarded to LSU—LSU Chemical...
XWELL_Black_CMYK.jpg
CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago
March 12, 2024 07:00 ET | XWELL, Inc.
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, the Centers for Disease Control and Prevention...
Accountability Needed for COVID Debacle, according to the Journal of American Physicians and Surgeons
December 13, 2023 11:51 ET | Association of American Physicians and Surgeons
Regulatory agencies and individuals, that have pervasive conflicts of interest, need to be held accountable for the disastrous COVID-19 response.
striim_logo.png
Striim Integrates with Microsoft Fabric to Deliver Real-Time Data Streaming Innovation for Analytics and AI
December 13, 2023 07:00 ET | Striim, Inc.
PALO ALTO, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Striim, an industry leader in real-time data integration and streaming, is excited to announce its integration with Microsoft Fabric, a new data...
Dyadic Logo Current.jpg
Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
November 20, 2023 08:30 ET | Dyadic International, Inc.
JUPITER, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...
TIP_link_300x300.jpg
Root Canal Market Size Worth $1.38 Billion, Globally, by 2028 - Comprehensive Report by The Insight Partners
November 01, 2023 06:44 ET | The Insight Partners
Pune, India, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Root canal management is intended to minimize or eliminate bacteria from the infected root canal, prevent reinfection of the tooth, and save the...
TIP_link_300x300.jpg
Smoking Cessation Aids Market Share Worth Nearly $64 Billion, Globally, by 2028 - Exclusive Report by The Insight Partners
November 01, 2023 06:38 ET | The Insight Partners
Pune, India, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Smoking cessation lowers the risk of cancer and other serious health problems. Some products contain nicotine as an active ingredient and others do...